Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.

In the assessment of 12-month price targets, analysts unveil insights for CVS Health, presenting an average target of $79.0, ...

Mirae Asset Global Investments Co. Ltd. juiced up its stake in CVS Health Corporation by a healthy 12.6%, showcasing a robust ...

CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.

We came across a bullish thesis on CVS Health Corporation on Microcapexpert’s Substack. In this article, we will summarize ...

CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Sri Narasimhan, vice president, head of enterprise, customer experience and insights at CVS Health, discusses how patient ...

CVS Health Corporation (NYSE:CVS) is one of the Best Dividend Stocks of 2025. Following a challenging year in 2024, CVS ...

Confluence Wealth Services Inc. increased its stake in CVS Health by a whopping 131.7% in the first quarter, now owning 9,541 ...